Preclinical Assets Market, by Service ( Bioanalysis and DMPK studies, Toxicology Testing, compound management, by Model type, by End user, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Preclinical assets consist of various types of services such as Bioanalysis and DMPK (Drug Metabolism and pharmacokinetics) studies, which are further sub segmented into in vitro and in vivo analysis, toxicology testing, which are based on GLP and non GLP (Good Laboratory Practices), compound management process R&D (Research and development), custom synthesis, asymmetric synthesis, and others (Scale-up, cGMP (current good manufacturing practices), safety pharmacology. Preclinical assets have two types of models, patient derived organoid (PDO) model and patient derived xenograft model.

Market Dynamics

Increasing number of service launch in preclinical testing by the key market players is expected to drive growth of the global preclinical assets market during the forecast period. For instance, in July 2020, Skinobs, a cosmetic company, announced the launch of a new preclinical testing platform skinobs, an independent tool which provides a 360-degree vision of in vivo efficacy testing. This platform enables users to identify and select the testing methods depending on various criteria such as

Test Category: which include analytical tests, content-contenair interaction, ecotoxicity and biodegradability tests, safety tests, UV (Ultra Violet ) tests, etc.
Claim: which include anti-ageing, anti-pollution, etc.
Test support: which include cell cultures, 3D skin models, etc.

Similarly, in December 2021, Sirona Medical, a software company, announced the launch of its cloud-native radiology operating system (RadOS) optimizing the use of novel AI (Artificial Intelligence) applications in clinical practice at the 2021 Annual Meeting for Radiological Society of North America (RSNA). The platform was based on the combination of technology and artificial intelligence, which would help augment the intelligence of the physician in clinical practices.

Key features of the study:

This report provides an in-depth analysis of the global preclinical assets market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global preclinical assets market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Eurofins Scientific, ICON plc, WuXi AppTec, Viroclinics Xplore, Medpace, Inc., Charles River Laboratories., Pharmatest Services, PPD Inc., SGS SA (SGS), Intertek Group plc, Labcorp Drug Development, Laboratory Corporation of America, Inc., Crown Bioscience, Comparative Biosciences, Inc., TCG Lifesciences Private Limited., Shanghai Medicilon Inc., Domainex, Absorption Systems, AmplifyBio, and IQVIA
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global preclinical assets market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical assets market

Detailed Segmentation:

Global Preclinical Assets Market, By Service:
- Bioanalysis and DMPK studies
  - In vitro
  - In-vivo
- Toxicology Testing
  - GLP
  - Non-GLP
- Compound Management
  - Process R&D
  - Custom Synthesis
  - Asymmetric Synthesis
  - Others (Scale-up, cGMP, etc.)
- Safety Pharmacology
- Others (Chemistry, etc.)
Global Preclinical Assets Market, By Model Type:
- Patient Derived Organoid (PDO) Model
- Patient derived xenograft model
Global Preclinical Assets Market, By End User:
- Biopharmaceutical Companies
- Government Institutes
- Others (Academic and Research institutes)
Global Preclinical Assets Market, By Region:
- North America
  - By Country
- US
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Eurofins Scientific*
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- ICON plc
- WuXi AppTec
- Viroclinics Xplore
- Medpace, Inc.
- Charles River Laboratories.
- Pharmatest Services
- PPD Inc.
- SGS SA (SGS)
- Intertek Group plc
- Labcorp Drug Development
- Laboratory Corporation of America, Inc.
- Crown Bioscience
- Comparative Biosciences, Inc.
- TCG Lifesciences Private Limited.
- Shanghai Medicilon Inc.
- Domainex
- Absorption Systems
- AmplifyBio
- IQVIA

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI5326

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service
- Market Snapshot, By Model Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technological Advancements
Regulatory Landscape
PEST Analysis

4. Global Preclinical Assets Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
COVID-19 Impact on the market

5. Global Preclinical Assets Market, By Service, 2017 - 2030, (US$ Million)

Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017- 2030
- Segment Trends
Bioanalysis and DMPK studies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
In vitro
In-vivo
Toxicology Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
GLP
Non-GLP
Compound Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Process R&D
Custom Synthesis
Asymmetric Synthesis
Others (Scale-up and cGMP)
Safety Pharmacology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others (Chemistry, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Preclinical Assets Market, By Model Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Patient Derived Organoid (PDO) Model
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Patient derived xenograft model
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Preclinical Assets Market, By End User, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Biopharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Government Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others (Academic and Research institutes)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Preclinical Assets Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Heat Map Analysis
Company Profile
- Eurofins Scientific
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- ICON plc
- WuXi AppTec
- Viroclinics Xplore
- Medpace, Inc.
- Charles River Laboratories.
- Pharmatest Services
- PPD Inc.
- SGS SA (SGS)
- Intertek Group plc
- Labcorp Drug Development
- Laboratory Corporation of America, Inc.
- Crown Bioscience
- Comparative Biosciences, Inc.
- TCG Lifesciences Private Limited.
- Shanghai Medicilon Inc.
- Domainex
- Absorption Systems
- AmplifyBio
- IQVIA
Analyst Views

10. Section

References
Research Methodology
About Us

Preclinical Assets Market, by Service ( Bioanalysis and DMPK studies, Toxicology Testing, compound management, by Model type, by End user, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030